|
FLNA Filana Therapeutics Inc 1069530 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-10,331,000.00 |
| Balance Sheet |
|
Current Assets
|
$87,964,000.00 |
|
Assets
|
$108,367,000.00 |
|
Current Liabilities
|
$40,115,000.00 |
|
Liabilities
|
$40,226,000.00 |
|
Equity
|
$68,141,000.00 |
|
Shares Out
|
48307896.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-8,878,000.00 |
|
Investing Cash Flow
|
$-581,000.00 |
| Market Analysis |
Market Cap
|
$45,409,422.24 |
|
Price
|
$0.94 |
|
BVPS
|
1.41 |
|
PB
|
0.67 |
|
EPS
|
-0.21 |
|
FCF
|
$-9,459,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:54 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:44 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
-0.21 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view FLNA documents filed with the SEC.
FLNA Filings
Clear
